Galantamine is a cholinesterase inhibitor primarily used in the treatment of mild to moderate Alzheimer’s disease, marketed under various brand names such as Razadyne. It enhances cognitive function by increasing the concentration of acetylcholine in the brain, thereby improving memory and awareness in affected individuals. Maintaining the pharmaceutical purity of Galantamine is essential to ensure its therapeutic effectiveness, minimize adverse effects, and meet regulatory standards. Impurity profiling is crucial to detect and control any unwanted substances that may form during synthesis, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 3 of 3 products
Catalogue No : GALA-OCL-001
CAS No : 1953-04-4
In Stock
Synonyms
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide
Catalogue No : GALA-OCL-002
CAS No : 134332-50-6
In Stock
Synonyms
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol N-Oxide
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol N-Oxide
Catalogue No : GALA-OCL-003
CAS No : 60755-80-8
In Stock
Synonyms
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol